Roma Landmark theaters, LLC v. Cohen Exhibition Company LLC ( 2020 )


Menu:
  •    IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
    )
    ROMA LANDMARK THEATERS, LLC              )
    and MCC ENTERTAINMENT LLC,               )
    )
    Plaintiffs,                    )
    )
    v.                                  )   C.A. No. 2019-0585-PAF
    )
    COHEN EXHIBITION COMPANY LLC,            )
    )
    Defendant.                    )
    ___________________________________      )
    )
    COHEN EXHIBITION COMPANY LLC,            )
    )
    Counterclaim-Plaintiff,        )
    )
    v.                                  )
    )
    ROMA LANDMARK THEATERS, LLC,             )
    MCC ENTERTAINMENT LLC, and               )
    SCHUYLER HANSEN,                         )
    )
    Counterclaim-Defendants.       )
    MEMORANDUM OPINION
    Date Submitted: June 12, 2020
    Date Decided: September 30, 2020
    Garrett B. Moritz and Anne M. Steadman, ROSS ARONSTAM & MORITZ LLP,
    Wilmington, Delaware; Marshall R. King and Hannah E. Kirshner, GIBSON,
    DUNN & CRUTCHER LLP, New York, New York; Attorneys for Plaintiffs and
    Counterclaim Defendants.
    Kevin M. Gallagher and Angela Lam, RICHARDS, LAYTON & FINGER, P.A.,
    Wilmington, Delaware; Donald A. Harwood and Simon W. Reiff, HARWOOD
    REIFF LLC, New York, New York; Attorneys for Defendant and Counterclaim
    Plaintiff.
    FIORAVANTI, Vice Chancellor
    2
    This action arises from a disagreement over post-closing price adjustments to
    a corporate acquisition. Under the parties’ purchase agreement, the company
    calculated certain financial metrics to determine initial adjustments to the purchase
    price and provided them to the buyer. The buyer updated the calculations after
    closing to determine a final adjustment to the purchase price.        The purchase
    agreement detailed how the financial metrics would be calculated. The agreement
    required the parties to submit any dispute over the calculations to an independent
    accounting firm for a conclusive and binding determination.
    The parties disagreed over post-closing adjustments and submitted their
    dispute to the accounting firm. The accounting firm largely ruled in favor of the
    sellers. The sellers then filed this action, requesting an order confirming the
    accounting firm’s decision and requiring the buyer to release funds which had been
    escrowed to satisfy any final purchase price adjustment. The buyer responded with
    counterclaims, alleging that the sellers have engaged in financial disclosure
    misrepresentations amounting to fraud and bad faith. The sellers have moved for
    summary judgment on their affirmative claims and to dismiss the buyer’s
    counterclaims.
    This Opinion grants the motion to dismiss in part and denies the motion for
    summary judgment.
    3
    I.    BACKGROUND
    The facts recited in this opinion are drawn from the Verified Complaint (Dkt.
    1) (the “Complaint” or “Compl.”), the Answer (Dkt. 24) (the “Answer” or “Ans.”),
    the Verified Amended Counterclaims (Dkt. 24) (the “Counterclaims” or
    “Countercl.”), documents integral thereto, and matters of which the Court may take
    judicial notice.
    A.     The Purchase Agreement
    On December 3, 2018, Plaintiffs Roma Landmark Theaters, LLC (“Roma”)
    and MCC Entertainment LLC (“MCC”) sold Landmark Acquisition Corporation
    (“Landmark” or the “Company”) to Defendant Cohen Exhibition Company LLC
    (the “Buyer”) pursuant to a Securities Purchase Agreement (the “Purchase
    Agreement”).1 The Counterclaims allege that Counterclaim Defendant Schuyler
    Hansen was the Chief Financial Officer and Manager of Roma and MCC, and the
    Chief Financial Officer of the Company at the time of the sale.2 Unless otherwise
    noted, Roma, MCC, and Hansen are referred to herein as the “Sellers.”
    1
    Compl. ¶ 12; Ans. ¶ 12. The Purchase Agreement is attached as Exhibit A to the
    Complaint.
    2
    The record does not contain a single authoritative source establishing the titles that
    Hansen held at Roma, MCC, and the Company. See Countercl. ¶ 10 (alleging that Hansen
    was the Sellers’ CFO and Manager); id. ¶ 34 (alleging that Hansen was the Company’s
    CFO prior to the sale); Hansen Decl. ¶ 1 (Dkt. 19) (identifying Hansen as the Manager of
    Roma); Determination Letter 1 (identifying Hansen as the Chief Financial Officer of both
    Roma and MCC); Purchase Agreement Schedule 1.5(b)(iv) (identifying Hansen as the
    Company’s CFO and Treasurer).
    4
    The Counterclaims largely implicate two categories of Purchase Agreement
    provisions: (1) the purchase price adjustment mechanism; and (2) the Sellers’ and
    the Company’s respective representations and warranties.
    1.     The Purchase Price Adjustments
    Under the Purchase Agreement, Buyer agreed to purchase the Company for
    $148,800,000, subject to adjustments at and after closing. Pursuant to the Purchase
    Agreement, Buyer placed $3 million of the purchase price into an escrow account to
    satisfy any post-closing adjustments.3 At closing, the price was adjusted based on
    financial metrics in a Preliminary Closing Statement that the Company provided to
    Buyer shortly before closing.       The Preliminary Closing Statement contained
    estimates of the Company’s Net Working Capital, Indebtedness, Cash, and
    Company Transaction Expenses as of the closing date.4 After closing, pursuant to
    the Purchase Agreement, the Buyer provided a Final Closing Statement to the Sellers
    3
    Purchase Agreement 38 (defining “Closing Payment” as the “Estimated Net Purchase
    Price Amount” minus the “Adjustment Escrow Amount” and the “Adjustment Escrow
    Amount” as $3,000,000); 40 (defining “Estimated Net Purchase Price Amount” as the
    “Enterprise Value” taking into account the financial metrics); 39 (defining “Enterprise
    Value” as $148,800,000); see also id. § 1.6; Compl. ¶ 13 (establishing $3 million escrow
    for post-closing adjustments). The Escrow Agreement is attached as Exhibit C to the
    Complaint.
    4
    Purchase Agreement § 1.3(a).
    5
    containing a revised price adjustment, reflecting Buyer’s updated calculations of the
    same financial metrics. 5
    The parties agreed that the financial metrics in the Preliminary and Final
    Closing Statements would be calculated pursuant to instructions in a Company
    Disclosure Letter attached to the Purchase Agreement (the “Applicable Accounting
    Principles”). 6 The Applicable Accounting Principles provided that the Preliminary
    and Final Closing Statements would be prepared using: (1) the terms of the Purchase
    Agreement, (2) a list of “Specific Policies,” and (3) the accounting methodology
    used by the Company in preparing certain prior financial statements (the “Interim
    Financial Statements”). 7 If the Purchase Agreement, the Specific Policies, or the
    5
    Id. § 1.3(b).
    6
    Id. § 1.3(a) (“Estimated Net Working Capital, Estimated Indebtedness, Estimated Cash
    and Estimated Company Transaction Expenses shall be calculated on a basis consistent
    with Section 1.3(a) of the Company Disclosure Letter and the accounting principles,
    practices, assumptions, conventions and policies referred to therein (the ‘Applicable
    Accounting Principles’)”). The Company Disclosure Letter is attached as Exhibit 3 to the
    Declaration of Schuyler Hansen, and the Applicable Accounting Principles are set forth at
    Section 1.3 of the Company Disclosure Letter (Dkt. 19 Ex. 3). See Lou R. Kling & Eileen
    T. Nugent, Negotiated Acquisitions of Companies, Subsidiaries and Divisions § 17.02 at
    17–23 (2020 ed.) (discussing mechanisms to calculate post-closing purchase price
    adjustments and recommending “adequate pre-signing due diligence into the accounting
    principles and policies underlying the financial statements of the business being acquired
    and express agreements between the parties as to any deviations from these principles and
    policies that are to be applicable to the preparation of the closing date balance sheet”).
    7
    Company Disclosure Letter § 1.3; see also Purchase Agreement § 4.6(a) (defining
    “Interim Financial Statements” as “the combined consolidated statements of operations of
    the Company and its Subsidiaries, for the twelve (12) months ended December 28, 2017
    and the ten (10) months ended October 25, 2018”).
    6
    Interim Financial Statements did not address a particular calculation, the Preliminary
    and Final Closing Statements were to be prepared according to generally accepted
    accounting principles (“GAAP”). 8 To further guide the process, the Purchase
    Agreement attached a document illustrating how each of the financial metrics would
    be calculated (the “Sample Statement”). The parties agreed in the Specific Policies
    that all calculations of Net Working Capital would “include only those accounts and
    line items set forth in the Sample Statement.” 9
    If the parties could not resolve a dispute over the calculations in the Final
    Closing Statement, the Purchase Agreement required that an independent accounting
    firm would decide the dispute.10 The accounting firm’s review was limited to
    determining whether the calculations had been correctly performed and whether the
    calculations were made pursuant to the Applicable Accounting Principles and the
    8
    Company Disclosure Letter § 1.3. The parties also agreed that, in the event of any
    conflict, (1) the Purchase Agreement would supersede the Specific Policies and the
    methodologies used to prepare the Interim Financial Statements, and (2) the Specific
    Policies would supersede the methodologies used to prepare the Interim Financial
    Statements. Id.
    9
    Company Disclosure Letter at Specific Policy (e). The Sample Statement is attached as
    Exhibit A to the Applicable Accounting Principles. It is also attached as Exhibit A to the
    Purchase Agreement.
    10
    Purchase Agreement § 1.3(d).
    7
    Sample Statement.11 The accounting firm’s determination was “conclusive and
    binding upon the parties” and is “not . . . subject to appeal or further review.” 12 The
    parties also agreed that they would pay the costs of “any dispute resolution . . .
    including the fees and expenses of the Independent Accounting Firm and of any
    enforcement of the determination thereof” proportionally to the degree of their
    success, as calculated by the accounting firm. 13
    2.   Pertinent Representations and Warranties
    Article III of the Purchase Agreement contains Sellers’ representations and
    warranties. Article III does not make any representations or warranties about the
    accuracy of any financial statements or the Preliminary Closing Statement. In
    Section 3.6 of the Purchase Agreement, Sellers expressly disclaim any
    representations outside of the representations made in Article III, except as modified
    11
    Id. (“The scope of the disputes to be resolved by the Independent Accounting Firm shall
    be limited to correcting mathematical errors and determining whether the items and
    amounts in dispute were determined in accordance with the Applicable Accounting
    Principles and the Sample Statement, and the Independent Accounting Firm is not to make
    any other determination, including any determination as to whether the Target Net Working
    Capital or any estimates on the Preliminary Closing Statement are correct, adequate or
    sufficient.”).
    12
    Id. (“Judgment may be entered upon the written determination of the Independent
    Accounting Firm in accordance with Section 8.10.”); see also id. § 8.10 (forum selection
    clause selecting Delaware courts for all actions “arising out of or relating to this Agreement
    or the transactions contemplated hereby”).
    13
    Id. § 1.3(e).
    8
    by the Company Disclosure Letter. 14 With respect to Article III, the Company
    Disclosure Letter modifies the Sellers’ representations in Sections 3.4 and 3.5, which
    are not relevant to the claims addressed in this Opinion.15
    Article IV of the Purchase Agreement separately states the Company’s
    representations and warranties. Section 4.6(a) makes representations and warranties
    as to the Interim Financial Statements, stating that each financial statement:
    (i) has been prepared based on the books and records of the Company
    . . . except as may be indicated in the notes thereto, (ii) has been
    prepared in accordance with GAAP applied on a consistent basis
    throughout the periods indicated (except as may be indicated in the
    notes thereto) and (iii) fairly presents, in all material respects, the
    consolidated or combined financial position and results of operations
    of the Company and WSH HoldCo, Inc., and their respective
    Subsidiaries (as applicable), as at the respective dates thereof and for
    the respective periods indicated therein, except as otherwise noted
    therein and subject, in the case of the Interim Financial Statements, to
    normal year-end adjustments and the absence of notes. 16
    14
    Id. § 3.6 (“Neither such Seller nor any of its Affiliates, nor any of its or their respective
    Representatives is making any representation or warranty on behalf of, or otherwise
    relating to, such Seller of any kind or nature whatsoever, oral or written, express or implied,
    except as expressly set forth in this Article III (as modified by the Company Disclosure
    Letter) and such Seller hereby disclaims any such other representations or warranties.”).
    15
    The Company Disclosure Letter contains a table showing the Sellers’ equity interests in
    the Company, as referenced in Section 3.4, and a table listing one broker entitled to a
    brokerage, finder’s, or similar fee, as referenced in Section 3.5. Company Disclosure
    Letter §§ 3.4, 3.5.
    16
    Purchase Agreement § 4.6(a).
    9
    In Section 2.6 of the Purchase Agreement, Buyer agreed that it had been
    “provided with full and complete access” to the Company’s books and records. 17 It
    also expressly disclaimed any reliance upon any representation or warranty or
    statement (including by omission) outside of Articles III and IV, as modified by the
    Company Disclosure Letter. Section 2.6 states, in pertinent part:
    The Buyer is a sophisticated purchaser and has made its own
    independent investigation, review and analysis regarding the Company
    and its Subsidiaries and the transactions contemplated hereby . . . . The
    Buyer and its Representatives have been provided with full and
    complete access to the . . . books and records . . . that they have
    requested . . . . The Buyer has not relied and is not relying on any
    statement (including by omission), representation or warranty, oral or
    written, express or implied, made by or on behalf of any Seller, the
    Company, or any of their respective Affiliates . . . and each of the
    Sellers and the Company . . . expressly disclaim any and all liability
    that may be based on such information or errors therein or omissions
    therefrom, except as expressly and specifically set forth in Article III
    (as modified by the Company Disclosure Letter), with respect to
    representations made by a Seller as to itself, and Article IV (as modified
    by the Company Disclosure Letter) with respect to representations
    made by the Company as to itself and its Subsidiaries. None of the
    Sellers, the Company or any of their respective . . . directors, officers,
    employees, [or] equity holders . . . shall have any liability to the Buyer
    or any other Person resulting from the use of, or any reliance on, any
    information, documents or materials made available to the Buyer . . . .
    None of the Sellers, the Company or their Affiliates, or any of their
    respective directors, officers, employees, equity holders . . . has made,
    directly or indirectly, any representation or warranty or statement
    (including by omission) with respect to the accuracy or completeness
    of any such information, documents or materials made available to (or
    otherwise acquired by) the Buyer . . . . 18
    17
    Id. § 2.6.
    18
    Id.
    10
    In Section 8.1 of the Purchase Agreement, the parties agreed that the parties’
    representations and warranties in the Purchase Agreement expired upon closing:
    The respective representations, warranties, covenants and agreements
    of the Sellers, the Company and the Buyer contained in this Agreement
    and any certificate delivered pursuant hereto shall terminate at, and not
    survive, the Closing; provided, that this Section shall not limit any
    covenant or agreement of the parties that by its terms requires
    performance after the Closing. In no event following the Closing shall
    the Buyer or the Company or their respective Affiliates have any
    recourse against (a) any Persons who were stockholders, equity holders,
    members or other direct or indirect beneficial owners of the Company
    prior to the Closing with respect to matters relating to the Company or
    (b) the former directors or officers of the Company or its Subsidiaries,
    or any Affiliates or Representatives of any of the foregoing Persons, in
    each case with respect to any representation, warranty, covenant or
    agreement made by the Company in this Agreement. 19
    The Buyer’s Counterclaims do not directly allege a breach of the
    representations and warranties in the Purchase Agreement. Rather, Buyer alleges
    that Sellers breached Sections 1.3(a) and 6.3(b) of the Purchase Agreement.20
    Section 1.3(a) is part of the purchase price adjustment mechanism. It requires the
    Company to prepare the Preliminary Closing Statement using good faith estimates
    of the financial metrics used to calculate the price adjustments, subject to the parties’
    agreement regarding the Applicable Accounting Principles and the Sample
    Statement. It states, in pertinent part:
    19
    Id. § 8.1.
    20
    Countercl. ¶ 19.
    11
    On or prior to the Closing Date . . . the Company shall prepare . . . and
    deliver to the Buyer [the “Preliminary Closing Statement”] setting forth
    (i) a good-faith estimate of the Company’s (A) Net Working Capital . .
    . (B) Indebtedness . . . (C) Cash . . . and (D) Company Transaction
    Expenses . . . each determined as of 11:59 p.m. on the day prior to the
    Closing Date . . . based on the Company’s books and records and other
    information available at the Closing and (ii) on the basis of the
    foregoing, a calculation of the Estimated Net Purchase Price Amount
    and the Closing Payment. Estimated Net Working Capital, Estimated
    Indebtedness, Estimated Cash and Estimated Company Transaction
    Expenses shall be calculated on a basis consistent with Section 1.3(a)
    of the Company Disclosure Letter and [the “Applicable Accounting
    Principles” therein]. An illustrative example of a Preliminary Closing
    Statement and calculation of Net Working Capital, Indebtedness, Cash
    and Company Transaction Expenses is set forth as Exhibit A (the
    “Sample Statement”). 21
    Section 6.3(b) is contained in Article VI of the Purchase Agreement, entitled
    “Conditions to Closing,” and states:
    The obligations of the Buyer to consummate the transactions
    contemplated by this Agreement shall be subject to the fulfillment, at
    or prior to the Closing, of each of the following conditions, any of
    which may be waived in writing by the Buyer in its sole discretion:
    ***
    (b) The Sellers and the Company shall have performed all obligations
    and agreements and complied with all covenants and conditions
    required by this Agreement to be performed or complied with by them
    prior to or at the Closing. 22
    21
    Purchase Agreement § 1.3(a).
    22
    Id. § 6.3(b).
    12
    B.     The Parties Dispute the Post-Closing Adjustments.
    On February 7, 2019, Buyer delivered the Final Closing Statement to the
    Sellers.23 On March 7, 2019, Sellers gave notice to Buyer that Sellers disputed
    certain calculations in Buyer’s Final Closing Statement. 24 The parties engaged
    PricewaterhouseCoopers LLP (“PwC”) to serve as the independent public
    accounting firm to resolve the disputes and submitted statements of their respective
    positions to PwC. 25 PwC propounded interrogatories and document requests to the
    parties to obtain additional information to assist it in its determination. 26
    On June 28, 2019, PwC issued its Determination Letter resolving the Final
    Closing Statement disputes.27 The Determination Letter resolved the disputes in
    Sellers’ favor, except that PwC agreed with Buyer’s calculation of the Company’s
    23
    Compl. ¶ 14; Ans. ¶ 14.
    24
    Compl. ¶ 15; Purchase Agreement § 1.3(c).
    25
    Compl. ¶¶ 14–15; see also Compl. Ex. D (PwC’s engagement letter). The Purchase
    Agreement indicates that “the Independent Accounting Firm shall be BDO Siedman or, if
    such firm is unable or unwilling to act, such other independent public account firm as shall
    be agreed in writing by the Sellers and the Buyer.” Purchase Agreement § 1.3(d). PwC
    was retained after BDO Siedman was determined to have a conflict of interest. Cherniak
    Aff. ¶ 19 (Dkt. 26).
    26
    Compl. Ex. B at 3.
    27
    PwC referred to its written decision as the “Determination Letter,” and this Opinion uses
    that defined term hereinafter. The Determination Letter is attached as Exhibit B to the
    Complaint.
    13
    cash as of the closing date. 28 Sellers requested that Buyer instruct the escrow agent
    to release funds pursuant to PwC’s determination. Buyer refused. 29
    C.     This Action
    On July 29, 2019, Sellers filed the Complaint seeking (1) a judgment
    enforcing PwC’s Determination Letter as a binding arbitration award under the
    Federal Arbitration Act (Compl. Count I);30 and (2) an order of specific performance
    requiring Buyer to release the escrowed amounts pursuant to the Determination
    Letter, plus Sellers’ costs of enforcement (Compl. Count II).31
    On September 13, 2019, Buyer filed an Answer and Verified Counterclaims,
    which were amended on January 13, 2020. The Counterclaims allege that Sellers,
    through their fellow Counterclaim-Defendant Hansen as an officer of the Sellers and
    the Company, engaged in bad faith and fraudulent conduct. Buyer alleges that
    Sellers acted fraudulently and in bad faith by failing to maintain a reserve against an
    accounts receivable balance for payments from Moviepass, a ticket subscription
    28
    Determination Letter 6–11 & 13–15 (resolving calculation disputes in Sellers’ favor); id.
    at 12 (resolving the dispute regarding Closing Cash in Buyer’s favor).
    29
    Compl. ¶¶ 26–27.
    30
    Id. ¶¶ 28–35.
    31
    Id. ¶¶ 36–42; Request for Relief ¶ b (requesting an order “directing specific performance
    of Cohen’s obligations under the Purchase Agreement and the Escrow Agreement to . . .
    execute a Joint Instruction Letter releasing funds to Plaintiffs in the amount of $2,621,623,
    plus any interest accrued in the Escrow Account since May 31, 2019, plus Plaintiffs’ costs
    of enforcement, plus prejudgment interest”).
    14
    business, in the Company’s Interim Financial Statements or in the Preliminary
    Closing Statement.         According to Buyer, Sellers knew that Moviepass was
    experiencing financial distress,32 but did not record a reserve. Buyer further alleges
    that Sellers did not properly record outstanding checks from a particular bank
    account (“Account #1000-035”) as accounts payable or otherwise disclose them to
    Buyer as liabilities in the Preliminary Closing Statement, even though Buyer listed
    outstanding checks as liabilities in its Interim Financial Statements.33
    The dispute over the Moviepass receivable and outstanding checks were
    among the issues previously presented to PwC.           The Buyer’s Final Closing
    Statement recorded a 50% reserve to the Moviepass accounts receivable and
    reclassified the outstanding checks as liabilities. PwC rejected Buyer’s argument
    and resolved the disagreement in Sellers’ favor. PwC determined that the Buyer’s
    treatment of the Moviepass accounts receivable and the outstanding checks in the
    Final Closing Statement was inconsistent with the Purchase Agreement. 34 Despite
    PwC’s determination, Buyer argues that the Determination Letter does not bar its
    32
    Countercl. ¶¶ 7–11.
    33
    Id. ¶¶ 12–22.
    34
    Determination Letter 6–7 (determining that Buyer had not acted consistently with the
    Sample Statement by reclassifying outstanding checks as accounts payable in the Final
    Closing Statement and stating: “Buyer’s proposed Moviepass accounts receivable reserve
    was not in accordance with the Specific Policies.”).
    15
    claims because PwC had no authority to determine whether Sellers acted
    fraudulently or in bad faith.
    The Counterclaims also assert claims that were, allegedly, not presented to
    PwC. The Counterclaims allege that, after PwC issued the Determination Letter,
    Buyer learned about multiple categories of liabilities that were excluded from the
    Interim Financial Statements and the Preliminary Closing Statement. Specifically,
    Buyer alleges that Sellers acted improperly by failing to disclose (1) more than
    $750,000 of merit and incentive bonuses for field management personnel (the
    “Management Bonus Liabilities”); (2) approximately $500,000 of medical claim
    liabilities known to Sellers prior to closing (the “Medical Claim Liabilities”); and
    (3) approximately $175,000 of under-accrued state income taxes, approximately
    $60,000 worth of expense reports, and a write-off of a receivable of approximately
    $40,000 (the “Miscellaneous Liabilities”).35
    Buyer’s counterclaims are reflected in four separate counts: (1) breach of
    contract for failure to provide good faith estimates of the Company’s financial
    metrics pursuant to Section 1.3 (Countercl. Count I);36 (2) fraud (Countercl. Count
    35
    Countercl. ¶¶ 25–26.
    36
    Id. ¶¶ 27–32.
    16
    II); 37 (3) fraudulent concealment (Countercl. Count IV); 38 and (4) breach of the
    implied covenant of good faith and fair dealing (Countercl. Count V). 39 The parties
    briefed Sellers’ motion to dismiss the Counterclaims and motion for summary
    judgment, and on June 12, 2020, the Court heard oral argument on the motions.
    II.      ANALYSIS
    A.     Sellers’ Motion to Dismiss
    Sellers have moved to dismiss Buyer’s counterclaims in their entirety. The
    pleading standards governing a motion to dismiss under Court of Chancery Rule
    12(b)(6) are minimal. Central Mortg. Co. v. Morgan Stanley Mortg. Cap. Hldgs.
    LLC, 
    27 A.3d 531
    , 536 (Del. 2011). On a motion to dismiss for failure to state a
    claim:
    (i) all well-pleaded factual allegations are accepted as true; (ii) even
    vague allegations are well-pleaded if they give the opposing party
    notice of the claim; (iii) the Court must draw all reasonable inferences
    in favor of the non-moving party; and ([iv]) dismissal is inappropriate
    unless the plaintiff would not be entitled to recover under any
    reasonably conceivable set of circumstances susceptible to proof.
    Savor, Inc. v. FMR Corp., 
    812 A.2d 894
    , 896–97 (Del. 2002) (internal citations and
    quotation marks omitted); accord Central Mortg., 
    27 A.3d at 536
    . “[A] trial court
    is required to accept only those ‘reasonable inferences that logically flow from the
    37
    
    Id.
     ¶¶ 33–38.
    38
    
    Id.
     ¶¶ 39–44. There is no Count III in the amended counterclaims.
    39
    
    Id.
     ¶¶ 45–51.
    17
    face of the complaint’ and ‘is not required to accept every strained interpretation of
    the allegations proposed by the plaintiff.’” In re Gen. Motors (Hughes) S’holder
    Litig., 
    897 A.2d 162
    , 168 (Del. 2006) (quoting Malpiede v. Townson, 
    780 A.2d 1075
    ,
    1083 (Del. 2001)). “Moreover, a claim may be dismissed if allegations in the
    complaint or in the exhibits incorporated into the complaint effectively negate the
    claim as a matter of law.” Malpiede, 
    780 A.2d at 1083
    .
    This Opinion first addresses Buyer’s contract claims in Count I (breach of
    contract) and Count V (breach of the implied covenant of good faith and fair
    dealing). The Opinion then addresses Buyer’s fraud claims in Count II (fraud) and
    Count IV (fraudulent concealment).
    1.     Buyer’s Contract Claims
    a.     Breach of Contract (Count I)
    “To survive a motion to dismiss, a complaint stating a claim for breach of
    contract must identify a contractual obligation . . . a breach of that obligation by the
    defendant, and resulting damage to the plaintiff.” Moore Bus. Forms, Inc. v.
    Cordant Hldgs. Corp., 
    1995 WL 662685
    , at *7 (Del. Ch. Nov. 2, 1995). “‘Delaware
    adheres to the ‘objective’ theory of contracts, i.e., a contract’s construction should
    be that which would be understood by an objective, reasonable third party.’” Osborn
    v. Kemp, 
    991 A.2d 1153
    , 1159 (Del. 2010) (quoting NBC Universal v. Paxson
    18
    Commc’ns Corp., 
    2005 WL 1038997
    , at *5 (Del. Ch. Apr. 29, 2005)); accord
    Salamone v. Gorman, 
    106 A.3d 354
    , 367–68 (Del. 2014).
    Buyer does not directly allege that Sellers breached the Company’s financial
    disclosures in the representations and warranties of the Purchase Agreement.
    Rather, Buyer attempts to do so indirectly, alleging breaches of two other contract
    provisions. 40 First, Buyer claims that Sellers breached Section 1.3 of the Purchase
    Agreement, which required the Company to provide good faith estimates of financial
    metrics in the Preliminary Closing Statement.            Second, Buyer claims Sellers
    breached a representation or covenant in Section 6.3(b) that the financial information
    provided by the Company to Buyer was accurate.
    In essence, Buyer argues that these provisions should serve as “backup”
    representations and warranties by the Sellers regarding the Company’s finances
    because Sellers did not make any representations or warranties regarding the
    Company’s financial disclosures in the Purchase Agreement. Rather, in Section
    4.6(a), the Company (not the Sellers) represented and warranted that the Interim
    Financial Statements had been prepared “based on the books and records of the
    Company” and “in accordance with GAAP applied on a consistent basis throughout
    40
    Defendant concedes that Hansen is not liable for breach of contract or for a breach of the
    implied covenant of good faith and fair dealing because Hansen was not a party to the
    Purchase Agreement. Buyer’s Ans. Br. in Opp’n to Mot. to Dismiss 42 n.2.
    19
    the periods indicated.” 41 In the same section, the Company further warranted that
    the Interim Financial Statements “fairly present[], in all material respects, the
    consolidated or combined financial position and results of operations of the
    Company . . . as at the respective dates thereof and for the respective periods
    indicated therein.”42 The parties expressly agreed that the representations and
    warranties terminated upon closing and barred any recourse by the Buyer against the
    former owners of the Company. 43
    In Section 1.3, outside of the representations and warranties described in
    Articles III and IV of the Purchase Agreement, the Company agreed that it would
    provide the Preliminary Closing Statement to the Buyer for purposes of calculating
    an initial price adjustment that would subsequently be revised by the Buyer after
    closing and reflected in the Final Closing Statement. The typical purpose of post-
    closing price adjustments is to “account for changes in [the] business between . . .
    signing and closing.” See Chicago Bridge & Iron Co. N.V. v. Westinghouse Elec.
    41
    Purchase Agreement § 4.6(a).
    42
    Id. See Abry P’rs V, L.P. v. F & W Acq. LLC, 
    891 A.2d 1032
    , 1041–42 (Del. Ch. 2006)
    (analyzing a purchase agreement in which the “key representation and warranty” was
    “made only by the Company and not by the Seller”). In Abry Partners, this Court held that
    it was “legitimate for the Seller to create exculpatory distance between itself and the
    Company” by dividing the representations in this manner so that the buyer would be
    required to “hold the Company and its speaking managers exclusively responsible for their
    own misstatements of fact.” 
    Id. at 1063
    .
    43
    Purchase Agreement § 8.1.
    20
    Co. LLC, 
    166 A.3d 912
    , 928 (Del. 2017); see also 
    id.
     (“Buyers want protection
    against value depletion before they take over the business, and, at the same time,
    sellers want to ensure that they will be compensated for effectively running the
    business.”).
    i.      The Counterclaims Do Not State a Claim for
    Breach of Section 1.3 of the Purchase
    Agreement.
    Section 1.3(a) requires the Company, rather than Sellers, to prepare the
    Preliminary Closing Statement. It states:
    [T]he Company shall prepare, or cause to be prepared, and deliver to
    the Buyer a statement (the “Preliminary Closing Statement”) setting
    forth (i) a good-faith estimate of the Company’s (A) Net Working
    Capital (the “Estimated Net Working Capital”), (B) Indebtedness (the
    “Estimated Indebtedness”), (C) Cash (the “Estimated Cash”) and (D)
    Company Transaction Expenses (the “Estimated Company Transaction
    Expenses”) [as of the closing date]. 44
    Section 1.3(a) does not obligate the Sellers to prepare the Preliminary Closing
    Statement or to provide good faith estimates of the Company’s financial metrics.
    The obligations of Sellers and the Company are not interchangeable in the Purchase
    Agreement. See Abry, 
    891 A.2d at 1063
     (noting that parties to an agreement
    apportioned representations between the company and the seller of the company
    because “[t]he Seller did not necessarily possess the same information as the
    managers of the Company”). Having agreed that the Company owed the obligation
    44
    Purchase Agreement § 1.3(a).
    21
    to prepare the Preliminary Closing Statement, Buyer cannot now argue that Sellers
    owed the contractual obligation to prepare and deliver the Preliminary Closing
    Statement pursuant to the Purchase Agreement with the attendant contractual
    liability for breach.
    In its briefing, Buyer’s only counterargument is that “a seller may be held
    liable for the company’s fraudulent misrepresentations in a stock purchase
    agreement.”45       Buyer cites no case law, however, for the proposition that a
    contracting party may be held liable for breach of contract for failure to disclose
    information that another party was obligated to disclose.46 To hold that Sellers owed
    the contractual obligation to prepare the Preliminary Closing Statement in good faith
    would be to rewrite the parties’ contract, and Buyer makes no argument that doing
    so would be appropriate here. See JPMorgan Chase & Co. v. Am. Century Cos.,
    Inc., 
    2012 WL 1524981
    , at *6 (Del. Ch. Apr. 26, 2012) (dismissing breach of
    contract claim because plaintiffs failed to cite any term of the contract obligating
    defendant to provide the disclosure allegedly required). Buyer’s claim that Sellers
    breached Section 1.3(a) of the Purchase Agreement is therefore dismissed.
    45
    Buyer Ans. Br. in Opp’n to Mot. to Dismiss 43 (emphasis in original).
    46
    See Oral Arg. Tr. at 59 (counsel for Buyer confirming same) (Dkt. 70).
    22
    ii.    The Complaint Fails to Allege that Sellers
    Breached Section 6.3(b).
    Buyer alleges that Sellers breached Section 6.3(b) of the Purchase Agreement.
    This claim is based on the same alleged financial misrepresentations underlying the
    alleged breach of Section 1.3(a).47 Section 6.3(b) states: “[T]he Sellers and the
    Company shall have performed all obligations and agreements and complied with
    all covenants and conditions required by this Agreement to be performed or
    complied with by them prior to or at the Closing.” 48 Buyer characterizes Section
    6.3(b) as a “disclosure requirement[]” and a “representation . . . that the interim
    financial statements were accurate as of the dates thereof.” See Buyer’s Ans. Br. in
    Opp’n to Mot. to Dismiss 20, 44. Elsewhere, Buyer contends that “[t]he promises
    made in Section 6.3(b) . . . most certainly were covenants” because it purportedly
    contains a “promise that accurate disclosures in good faith would occur[.]” 
    Id.
     46–
    47.
    Buyer’s various characterizations of Section 6.3(b) do not sustain a claim for
    breach of contract. Section 6.3(b) is a condition to closing, not (as Buyer claims) a
    representation and warranty of financial disclosures or a covenant that accurate
    47
    See Countercl. ¶ 19 (“In agreeing to close, Buyer relied on the truth and accuracy of the
    interim financial statements and the Preliminary Closing Statement and that Sellers would
    abide by their obligation under Section 1.3(a) of the Purchase Agreement to prepare such
    statements in good faith, as well as their representation under Section 6.3(b) that the interim
    financial statements were accurate as of the dates thereof.”).
    48
    Purchase Agreement § 6.3(b).
    23
    financial disclosures would be provided. “[T]he non-occurrence of a condition is
    not considered a breach unless the party promised that the condition would occur.”
    TravelCenters of Am. LLC v. Brog, 
    2008 WL 5272861
    , at *3 (Del. Ch. Dec. 5, 2018).
    Here, Buyer has neither pleaded nor demonstrated through briefing how Section
    6.3(b)—either by its terms or by reference to other provisions in the Purchase
    Agreement—obligates the Sellers to provide true and accurate representations
    regarding the Company’s financial disclosures.
    In alleging claims for breach of Sections 1.3(a) and 6.3(b), Buyer has sought
    to circumvent the clear contractual limitations that prevent a direct claim for breach
    of the Company’s financial representations. Under the Purchase Agreement, the
    Company, rather than the Sellers, provided representations and warranties regarding
    the Company’s financial statements.49             The truth and correctness of the
    representations and warranties were part of a condition to closing in Section 6.3(a),
    49
    Purchase Agreement § 4.6(a)(iii) (representing that financial statements “fairly present[],
    in all material respects, the consolidated or combined financial position and results of
    operations”). Cf. Abry, 
    891 A.2d at
    1041–44 (analyzing a situation in which a Stock
    Purchase Agreement contained a representation regarding financial statements by the
    company rather than the seller).
    24
    rather than Section 6.3(b). 50 In addition, the Company’s representations, warranties,
    and covenants terminated upon closing.51 Having agreed to those terms, Buyer
    cannot create new free-floating contractual protections that it did not bargain for
    through an unrelated provision of the Purchase Agreement. Nemec v. Shrader, 
    991 A.2d 1120
    , 1126 (Del. 2010) (“Parties have a right to enter into good and bad
    contracts, the law enforces both.”). Buyer has not stated a claim that Sellers
    breached the Purchase Agreement.
    b.      Breach of the Implied Covenant (Count V)
    Count V asserts a claim for breach of the implied covenant of good faith and
    fair dealing. Buyer alleges the Sellers breached the implied covenant by “providing
    misleading financial metrics, which significantly overstated the Company’s
    50
    Purchase Agreement § 6.3(a) (“The representations and warranties of the Sellers and the
    Company contained in Articles III and IV shall be true and correct both when made and as
    of the Closing Date, except that in the case of representations and warranties that are made
    as of a specified date, such representations and warranties shall be true and correct as of
    such specified date, except where the failure to be so true and correct (without giving effect
    to any limitation or qualification as to ‘materiality’ (including the word ‘material’), ‘Seller
    Material Adverse Effect’ or ‘Material Adverse Effect’ set forth therein, other than those
    limitations and qualifications contained in Section 4.7(b) and Section 4.17(a)) would not
    have or reasonably be expected to have a Seller Material Adverse Effect or Material
    Adverse Effect, as applicable.”).
    51
    Purchase Agreement § 8.1. “‘[W]here the contract expressly provides that the
    representations and warranties terminate upon closing . . . the parties have made clear their
    intent that they can provide no basis for a post-closing suit seeking a remedy for an alleged
    misrepresentation. That is, when the representations and warranties terminate, so does any
    right to sue on them.’” Chicago Bridge, 166 A.3d at 932–33 (quoting GRT, Inc. v.
    Marathon GTF Tech., Ltd., 
    2011 WL 2682898
    , at *13 (Del. Ch. July 11, 2011)).
    25
    Accounts Receivable, and grossly understated its Accounts Payable, both in the
    interim financial statements and in the Preliminary Closing Statement.” 52
    The implied covenant of good faith and fair dealing inheres in every contract
    governed by Delaware law and requires “‘a party in a contractual relationship to
    refrain from arbitrary or unreasonable conduct which has the effect of preventing the
    other party to the contract from receiving the fruits’ of the bargain.”53
    “[T]he implied covenant only applies where a contract lacks specific language
    governing an issue and the obligation the court is asked to imply advances, and does
    not      contradict,    the   purposes   reflected   in   the   express   language   of
    the contract.” Alliance Data Sys. Corp. v. Blackstone Capital P’rs V L.P., 
    963 A.2d 746
    , 770 (Del. Ch.), aff'd, 
    976 A.2d 170
     (Del. 2009) (TABLE). “The doctrine thus
    operates only in that narrow band of cases where the contract as a whole speaks
    sufficiently to suggest an obligation and point to a result, but does not speak directly
    enough to provide an explicit answer.” Airborne Health, Inc. v. Squid Soap, LP, 
    984 A.2d 126
    , 146 (Del. Ch. 2009); see also Oxbow Carbon & Minerals Hldgs., Inc. v.
    Crestview-Oxbow Acq., LLC, 
    202 A.3d 482
    , 504 n.93 & 506–07 (Del. 2019)
    (discussing the application of the implied covenant of good faith and fair dealing).
    52
    Countercl. ¶ 47.
    53
    Dunlap v. State Farm Fire & Cas. Co., 
    878 A.2d 434
    , 442 (Del. 2005) (quoting Wilgus
    v. Salt Pond Inv. Co., 
    498 A.2d 151
    , 159 (Del. Ch. 1985)).
    26
    Buyer neither alleges in its Counterclaims nor argues in its brief that there is
    a contractual gap or unanticipated development in the Purchase Agreement that
    should be addressed through application of the implied covenant of good faith and
    fair dealing. Rather, Buyer argues that its implied covenant claim should survive as
    an alternative to its primary breach of contract claim because “Delaware courts
    routinely deny dismissal of breach of covenant of good faith and fair dealing claims
    . . . prior to discovery.” 54
    Claims for the implied covenant of good faith and fair dealing are not immune
    from dismissal at the pleadings stage, especially where, as here, the claimant has not
    alleged an implied obligation or a contractual gap. See Winshall v. Viacom Int’l.,
    Inc., 
    76 A.3d 808
    , 816 (Del. 2013) (affirming dismissal of an implied covenant claim
    at the motion to dismiss stage because “no such obligation can be implied under” the
    contract); Dunn v. FastMed Urgent Care, P.C., 
    2019 WL 4131010
    , at *5 (Del. Ch.
    Aug. 30, 2019) (dismissing an implied covenant claim because plaintiff “does not
    allege the implied covenant fills a gap, nor . . . any misuse of a granted discretionary
    power”). In Fortis Advisors, this Court dismissed an implied covenant claim
    because the plaintiff had failed to “identif[y] an ambiguity or potential gap in a
    contract that could be filled by the implied covenant,” and noted that the “right to
    54
    Buyer’s Ans. Br. in Opp’n to Mot. to Dismiss 49–50.
    27
    plead alternative claims . . . does not obviate the need to provide factual support for
    each theory.” Fortis Advisors LLC v. Dialog Semiconductor PLC, 
    2015 WL 401371
    ,
    at *5 (Del. Ch. Jan. 30, 2015) (internal citations omitted). The same rationale holds
    here, and the implied covenant claim is therefore dismissed.
    2.     Buyer’s Fraud Claims
    Although Buyer cannot assert breach of contract claims against Sellers based
    upon any misrepresentations by the Company, Delaware law recognizes that a seller
    can, under certain circumstances, be held liable for fraud based on the company’s
    misrepresentations. Abry, 
    891 A.2d at 1064
    ; Prairie Capital III, L.P. v. Double E.
    Hldg. Corp., 
    132 A.3d 35
    , 60–62 (Del. Ch. 2015); ChyronHego Corp. v. Wight, 
    2018 WL 3642132
    , at *10 (Del. Ch. July 31, 2018). The Buyer must, nevertheless, satisfy
    the heightened pleading standard for fraud. A key element of that analysis involves
    the extent to which a buyer has disclaimed reliance on representations, thus negating
    an essential element of a claim for fraud. Here, Buyer has asserted two claims
    sounding in fraud: fraud, and fraudulent concealment.
    a.    Fraud (Count II)
    In Count II (Fraud), Buyer alleges that Sellers “including by and through
    Hansen, the Company’s then CFO and a Manager of Sellers, made false and
    28
    misleading statements of material facts concerning the calculation of Closing Net
    Working Capital and/or actively concealed such material facts.”55
    To state a claim for fraud, Buyer must plead: (1) that Counterclaim
    Defendants made a false representation, usually one of fact; (2) with the knowledge
    or belief that the representation was false, or with reckless indifference to the truth;
    (3) with an intent to induce Buyer to act or refrain from acting; (4) that Buyer’s
    action or inaction was taken in justifiable reliance upon the representation; and (5)
    damage to the plaintiff as a result of Buyer’s reliance on the representation. Fortis
    Advisors, 
    2015 WL 401371
    , at *6; accord GreenStar IH Rep, LLC v. Tutor Perini
    Corp., 
    2017 WL 5035567
    , at *10 (Del. Ch. Oct. 31, 2017), aff’d, 
    186 A.3d 799
     (Del.
    2018) (TABLE). To plead fraud, Buyer must also satisfy the heightened pleading
    standard of Court of Chancery Rule 9(b). Rule 9(b) states that “the circumstances
    constituting fraud or mistake shall be stated with particularity. Malice, intent,
    knowledge and other condition of mind of a person may be averred generally.” Ct.
    Ch. R. 9(b). “Speculative conclusions unsupported by fact do not allege fraudulent
    conduct.” Trenwick Am. Litig. Tr. v. Ernst & Young, L.L.P., 
    906 A.2d 168
    , 210 (Del.
    Ch. 2006), aff’d sub nom. Trenwick Am. Litig. Tr. v. Billett, 
    931 A.2d 438
     (Del.
    2007).
    55
    Countercl. ¶ 34.
    29
    Buyer’s fraud claims are based on the Interim Financial Statements and the
    Preliminary Closing Statement. According to Buyer, Counterclaim Defendants
    knowingly provided false representations about the Company’s financial condition
    in the Interim Financial Statements and the Preliminary Closing Statement, which
    induced Buyer to enter into the Purchase Agreement.
    i.     Fraud Claims Based upon the Interim Financial
    Statements
    Buyer’s fraud claim arising from alleged misrepresentations in the Interim
    Financial Statements are not barred by the terms of the Purchase Agreement. The
    Interim Financial Statements are the subject of a contractual representation that the
    parties agreed Buyer relied on in entering into the Purchase Agreement. Section 2.6
    states that the Buyer has not relied on any representation or warranty “except as
    expressly and specifically set forth in Article III . . . and Article IV.” 56 In Article IV,
    Section 4.6(a) of the Purchase Agreement, the Company represented that the Interim
    Financial Statements would “fairly present[], in all material respects, the
    consolidated or combined financial positions and results of operations of the
    Company.” 57 Even though Section 4.6(a) relates to a representation and warranty
    provided by the Company, Sellers may nevertheless be liable for the Company’s
    56
    Purchase Agreement § 2.6.
    57
    Id. § 4.6(a).
    30
    fraudulent misrepresentations in a contractual representation or warranty. See Abry,
    
    891 A.2d at 1064
     (holding that sellers may be held liable for fraud arising from the
    company’s contractual representations and warranties); Prairie Capital, 
    132 A.3d 35
     at 60–62 (discussing the same).
    Counterclaim Defendants acknowledge the foregoing principles and concede
    that Buyer’s fraud claim arising from alleged misrepresentations in the Interim
    Financial Statements “could theoretically survive the contractual terms.”58
    Counterclaim Defendants argue, however, that Buyer has not pleaded fraud with the
    requisite particularity. 59 As the Court observed in Prairie Capital, “[w]hen a party
    sues based on a written representation in a contract . . . it is relatively easy to plead
    a particularized claim of fraud” because:
    The plaintiff can readily identify who made what representations where
    and when, because the specific representations appear in the contract.
    The plaintiff likewise can readily identify what the defendant gained,
    which was to induce the plaintiff to enter into the contract. Having
    58
    Sellers’ Reply Br. in Supp. of. Mot. to Dismiss 16 n.14 (“The Counterclaim Defendants
    have maintained that Cohen’s fraud claims related to the Interim Financial Statements are
    not expressly precluded by the Purchase Agreement and therefore may be considered by
    the Court, but should be dismissed because they are not adequately pleaded.”). The parties
    did not argue, and this Opinion does not address, whether the fraud claim arising from the
    Interim Financial Statements is barred as a consequence of the parties’ agreement that all
    representations and warranties terminate upon closing. See Pilot Air Freight, LLC v.
    Manna Freight Systems, Inc., 
    2020 WL 5588671
    , at *20–21 (Del. Ch. Sept. 18, 2020)
    (rejecting “heretofore-uncharted” argument that expiration of a survival provision
    regarding representations and warranties precluded fraud claim based on expired
    representation because the contract contained a provision “preserv[ing the] right to bring
    intentional fraud claims at any time”) (internal quotations omitted).
    59
    Sellers’ Reply Br. in Supp. of. Mot. to Dismiss 2, 15–21.
    31
    pointed to the representations, the plaintiff need only allege facts
    sufficient to support a reasonable inference that the representations
    were knowingly false.
    Prairie Capital, 132 A.3d at 62; see also Abry, 
    891 A.2d at 1064
     (holding that a
    party may obtain damages where the buyer can show that “the Seller knew that the
    [Company’s] contractual representations and warranties were false”); 
    id. at 1050
    (“While knowledge may be pled generally, when a plaintiff pleads a claim of fraud
    that charges that the defendants knew something, it must allege sufficient facts from
    which it can reasonably be inferred that this ‘something’ was knowable and that the
    defendants were in a position to know it.”).
    The Counterclaims allege that Sellers committed fraud through the Interim
    Financial Statements by (1) failing to record a reserve for Moviepass; and (2)
    wrongfully excluding the Management Bonus Liabilities, the Medical Claim
    Liabilities, and the Miscellaneous Liabilities. 60 As discussed below, Sellers have not
    stated a claim for fraud arising from Sellers’ alleged conduct regarding Moviepass
    or the Miscellaneous Liabilities. The Counterclaims, however, do state a claim that
    60
    The Counterclaims do not allege that the outstanding checks were fraudulently omitted
    from the Interim Financial Statements because it appears that they were included in those
    statements. See Countercl. ¶¶ 13–15 (alleging that the outstanding checks were included
    in the 2017 audited financial statements and the Company’s 2018 balance sheet); Purchase
    Agreement § 4.6(a) (defining the “Balance Sheet” as the “unaudited combined
    consolidated balance sheet of the Company and its Subsidiaries, as of October 25, 2018”
    and the “Interim Financial Statements” as “the combined consolidated statements of
    operations of the Company and its Subsidiaries, for the twelve (12) months ended
    December 28, 2017 and the ten (10) months ended October 25, 2018”).
    32
    Sellers acted fraudulently by excluding the Management Bonus Liabilities and the
    Medical Claim Liabilities from the Interim Financial Statements.
    a.    Claims Based upon the Failure to Record
    a Reserve for Moviepass
    Buyer alleges that Counterclaim Defendants committed fraud because the
    Company failed to record a reserve for the Moviepass accounts receivable in the
    Interim Financial Statements. Setting a reserve is a matter of judgment that “requires
    management to perform a series of ongoing estimates using its best judgment.”
    Interim Healthcare, Inc. v. Spherion Corp., 
    884 A.2d 513
    , 574 (Del. Super. 2005).
    To state a claim of fraud relating to statements about a company’s expected future
    financial performance, it is necessary to plead “contemporaneous fact[s] supporting
    an inference [defendant] knew its statements were false when made or lacked a good
    faith belief in their truth.” Mooney v. E.I. du Pont de Nemours and Co., 
    2017 WL 5713308
    , at *6 (Del. Super. Nov. 28, 2017).
    In support of its claim that Sellers acted fraudulently by failing to record a
    reserve for Moviepass, Buyer alleges that (1) “there was a decline in payments that
    the Company received from Moviepass in the months prior to the closing”; (2) the
    Company’s “practice [was] to estimate reserves for doubtful accounts”; and (3) “[i]n
    internal email correspondence prior to the Closing the Company made clear its
    33
    concern regarding the Moviepass receivable.” 61 In its briefing, Buyer argues that its
    “reference to intracompany emails” reflecting knowledge of risks relating to the
    Moviepass accounts receivable is sufficient to plead a claim of fraud. 62
    These allegations are not sufficient to sustain a claim of fraud arising from an
    estimate of the Company’s future financial performance. The Counterclaims are
    conspicuously devoid of any allegation linking Sellers to the Company’s “concern”
    regarding Moviepass, as allegedly reflected in Company emails. 63                      The
    Counterclaims also do not contain particularized allegations regarding the timing or
    61
    Countercl. ¶¶ 7–11.
    62
    Buyer’s Ans. Br. in Opp’n to Mot. to Dismiss 33.
    63
    At oral argument, when confronted with the absence of additional facts regarding the
    emails in Buyer’s possession evidencing the Company’s “concern” regarding Moviepass,
    Buyer argued that, “to the extent the fraud claim as to Moviepass is dismissed, perhaps it
    would be dismissed without prejudice to repleading.” Oral Arg. Tr. at 43–44 (arguing that
    “we certainly can plead that these emails were post-closing, that these were not . . .
    something that we could have discovered prior to the closing, because they were not made
    available to us”). Dismissal without prejudice with leave to amend is not appropriate here.
    Buyer stood on its Amended Counterclaims by filing an answering brief pursuant to Court
    of Chancery Rule 15(aaa), and Buyer has not established good cause for the Court to
    provide leave to amend. See Mooney, 
    2017 WL 5713308
    , at *8 (“The parties went through
    full briefing and argument, yet Mooney did not once identify any additional allegations
    that might bolster his claim. Mooney’s failure to identify any misstatements of fact on
    which he relied or any contemporaneous fact suggesting DuPont’s statements were false
    when made are not defects easily resolved through an amended complaint. If Mooney
    possessed such facts, he had ample opportunity to identify them.”); see also Larkin v. Shah,
    
    2016 WL 4485447
    , at *21 (Del. Ch. Aug. 25, 2016) (“Plaintiffs’ conditional request to
    amend is not a procedurally proper motion to amend. More importantly, Plaintiffs have
    not shown, or even attempted to show, good cause as to why dismissal with prejudice
    would be unjust.”).
    34
    magnitude of Moviepass’s deterioration, nor do they allege any fact from which the
    Court could reasonably infer that Sellers knew that the Company would no longer
    receive any payments owed by Moviepass. On the contrary, while not dispositive,
    Buyer’s Final Closing Statement reflected a 50% reserve against the outstanding
    Moviepass balance, indicating that the Buyer believed the Company reasonably
    expected to obtain at least some payments from Moviepass and that the amount of
    any reserve remained a question of judgment. 64 Because Buyer has not pleaded
    “contemporaneous fact[s] supporting an inference [defendant] knew its statements
    were false when made or lacked a good faith belief in their truth,” the fraud claim
    relating to the Moviepass receivable fails. Mooney, 
    2017 WL 5713308
    , at *6.
    64
    Comparing the allegations in the Counterclaims to the allegations in Anschutz Corp. v.
    Brown Robin Capital, LLC, 
    2020 WL 3096744
     (Del. Ch. June 11, 2020), is instructive. In
    Anschutz, this Court denied a motion to dismiss a fraud claim based on “allegedly
    misleading entries in the interim financial statements” because the statements included
    accounts receivable from customers from which the company could no longer expect to
    receive payment. See id. at *12 (plaintiff alleging that the interim financial statements
    included accounts receivable from customers that had “disconnected all . . . services
    months earlier, were shutting down operations or were otherwise unwilling or unable to
    settle their accounts”). In Anschutz, plaintiff pleaded factual circumstances from which it
    was reasonably inferable that the preparer of the interim financial statements knew that it
    would no longer receive payments from customers. By contrast, in the present case, Buyer
    has only alleged that Moviepass paid less to the Company at some point prior to closing,
    without any supporting allegations.
    35
    b.     Claims Based upon the Management
    Bonus Liabilities, the Medical Claim
    Liabilities, and the Miscellaneous
    Liabilities
    Buyer alleges that the Interim Financial Statements support a claim of fraud
    because Sellers knowingly excluded liabilities from the financial statements in order
    to induce Buyer to close.      As noted above, “it is relatively easy to plead a
    particularized claim of fraud” “based on a written representation in a contract,”
    because the allegedly false contractual representation satisfies much of the
    requirement to plead a claim of fraud with particularity. Prairie Capital, 132 A.3d
    at 62. The only remaining allegations necessary are “facts sufficient to support a
    reasonable inference that the representations were knowingly false.” Id. In Abry
    Partners, the Court held that, to plead knowledge in this context, the plaintiff must
    “allege sufficient facts from which it can reasonably be inferred that [the falsity] was
    knowable and that the defendants were in a position to know it.” Abry, 
    891 A.2d at 1050
    . “Generally, it may be said that an allegation of fraud is legally sufficient under
    Rule 9(b) if it informs defendants of the precise transactions at issue, and the fraud
    alleged to have occurred in those transactions, so as to place defendants on notice of
    the precise misconduct with which they are charged.” Kahn Bros. & Co., Inc. Profit
    Sharing Plan & Tr. v. Fischbach Corp., 
    1989 WL 109406
    , at *4 (Del. Ch. Sept. 19,
    1989) (internal citations omitted); accord Bamford v. Penfold, L.P., 
    2020 WL 967942
    , at *12 (Del. Ch. Feb. 28, 2020). “Given that state of mind and knowledge
    36
    may be averred generally when pleading fraud, an allegation that a contractual
    representation is knowingly false typically will be deemed well pled (even if
    ultimately difficult to prove).” Pilot Air Freight, 
    2020 WL 5588671
    , at *24.
    Under the circumstances of this case, the Counterclaims have pleaded a claim
    of fraud arising from the failure to include the Management Bonus Liabilities and
    the Medical Claim Liabilities in the Interim Financial Statements, which the
    Company represented and warranted “fairly present[ed], in all material respects, the
    consolidated or combined financial positions and results of operations of the
    Company” at Section 4.6(a) of the Purchase Agreement. Buyer has alleged that the
    Interim Financial Statements wrongly excluded “merit increases for certain field
    management personnel . . . based upon defined goals and milestones, as well as
    incentives based on performance targets.”65 The Counterclaims allege that incentive
    bonuses in 2018 approximated $750,000, and merit increases effective in 2019
    approximated $144,000.66 Similarly, the Counterclaims allege that Sellers knew of
    the Medical Claim Liabilities prior to the closing of the transaction, which
    approximated $500,000.67
    65
    Countercl. ¶ 25.
    66
    
    Id.
    67
    Id. ¶ 26.
    37
    These liabilities were “knowable,” and given Hansen’s role as the CFO of the
    Company and as the Manager of Sellers, as well as the nature and magnitude of the
    liabilities, it is reasonably inferable that Hansen was in a position to know of these
    liabilities excluded from the Interim Financial Statements. Abry, 
    891 A.2d at 1050
    (holding that knowledge is adequately pleaded where the claimant alleges “sufficient
    facts from which it can reasonably be inferred that [the false information] was
    knowable and that the defendants were in a position to know it”); EMSI Acq., Inc. v.
    Contrarian Funds, LLC, 
    2017 WL 1732369
    , at *13 (Del. Ch. May 3, 2017) (quoting
    the same and rejecting an argument to adopt a “more stringent pleading standard for
    common law fraud”); see also Prairie Capital, 132 A.3d at 59–61 (holding that the
    sellers and the directors of the sellers may be liable, at the pleading stage, for
    representations made by the company in a contract). Although the allegations
    supporting Buyer’s claims for fraud arising from the Management Bonus Liabilities
    and the Medical Claim Liabilities are thin, they are sufficient to plead a claim under
    Court of Chancery Rule 9(b).
    Buyer’s fraud claims arising from the failure to include the Miscellaneous
    Liabilities in the Interim Financial Statements, however, do not cross the Rule 9(b)
    threshold. In Paragraph 26 of the Counterclaims, Buyer alleges:
    Likewise, Defendant subsequently learned of medical claim liabilities,
    which were known to Sellers prior to closing, of roughly $500,000; of
    under-accrued state income taxes of roughly $175,000; of expense
    reports of roughly $60,000; and, an inter-company write-off of a
    38
    receivable from Magnolia in an amount of roughly $40,000, among
    others. These items expressly should have been included as part of the
    Preliminary Closing Statement because it was within the standard
    practice of the Company prior to the Closing to include such items in
    the Company’s financial statements, and certainly should have been
    included as part of the Company’s interim financial statements. None
    of them were included. 68
    There are no additional substantive allegations as to the Miscellaneous Liabilities.
    In sum, Buyer alleges that there were a few miscellaneous line items that were not
    included in the Interim Financial Statements that should have been included. That
    is not enough to state a claim for fraud. Buyer does not allege that Sellers knew of
    the under-accrued state income taxes, expense reports, or write-off.69 Because the
    Counterclaims do not allege that Sellers knew of the Miscellaneous Liabilities, a
    fraud claim cannot survive regarding their purported omissions from the Interim
    Financial Statements.
    ii.   The Fraud Claim Based upon the Preliminary
    Closing Statement
    The parties sharply dispute whether Buyer has disclaimed reliance upon the
    Preliminary Closing Statement under Section 2.6 of the Purchase Agreement. Even
    assuming that Buyer has not disclaimed reliance upon the Preliminary Closing
    Statement, however, Buyer has not adequately pleaded a claim of fraud arising from
    68
    Countercl. ¶ 26.
    69
    Id.
    39
    the accounting treatment of the outstanding checks, which is the only category of
    alleged financial misrepresentation unique to the Preliminary Closing Statement and
    that this Opinion has not already resolved. 70 Under the Purchase Agreement, the
    parties agreed that the calculation of the Company’s Net Working Capital would
    “include only those accounts and line items set forth in the Sample Statement.”71
    Account #1000-035 was not included in the list.72 Because Buyer agreed that
    Account #1000-035 would not be included in calculations of Net Working Capital,
    Buyer cannot now claim that it was defrauded by the exclusion of that account. Abry,
    
    891 A.2d at 1058
     (“For the plaintiff in such a situation to prove its fraudulent
    70
    See supra n.59 (discussing the inclusion of outstanding checks in the Interim Financial
    Statements).
    71
    Applicable Accounting Principles § 1.3(a) at Specific Policy (e). Buyer also agreed that
    the Specific Policies, which require the accounts in the Sample Statement to be used to
    calculate Net Working Capital, would govern in the event of any conflict between the
    Specific Policies and the Interim Financial Statements. Applicable Accounting Principles
    § 1.3(a) (“For the avoidance of doubt, in the event of any conflict . . . section (ii) shall take
    precedence over sections (iii) and (iv)[.]”). Section (ii) requires the Preliminary and Final
    Closing Statements to be prepared in accordance with the Specific Policies. Id. Section
    (iii) requires the Preliminary and Final Closing Statements to be prepared in accordance
    with the Interim Financial Statements “to the extent not addressed in section (ii).” Id. The
    Specific Policies state that “[t]here should be no change in the classification . . . to a current
    liability of any liability that has not previously been characterized as a current liability.”
    Id. The Sample Statement contained specific account numbers and a description of each
    and whether each account was or was not included in “Working Capital.” Purchase
    Agreement Ex. A.
    72
    Even if Sellers subsequently determined that the outstanding checks in Account #1000-
    035 were not classified correctly, the parties agreed that Sellers could not reclassify “any
    liability that has not previously been characterized as a current liability” “to a current
    liability.” Applicable Accounting Principles § 1.3(a) at Specific Policy (e).
    40
    inducement claim, it proves itself not only a liar, but a liar in the most inexcusable
    of commercial circumstances: in a freely negotiated written contract . . . . To allow
    the buyer to prevail on its claim is to sanction its own fraudulent conduct.”). Further,
    as discussed below, there is no well-pleaded allegation that Sellers concealed
    Account #1000-035 from Buyer, or that Buyer was prevented from obtaining due
    diligence regarding Account #1000-035. Buyer’s claim for fraud arising from the
    outstanding checks therefore fails.
    Buyer’s fraud claim based on the Preliminary Closing Statement fails for the
    independent reason that Buyer agreed that it was not relying on any statement,
    representation, or warranty by the Sellers or the Company except as set forth in
    Article III and Article IV. 73 Section 2.6 expressly states that Buyer has “not relied
    and is not relying on any statement (including by omission), representation or
    warranty . . . except as expressly and specifically set forth in Article III (as modified
    by the Company Disclosure Letter) . . . and Article IV (as modified by the Company
    Disclosure Letter).”74 The parties further agreed that Sellers disclaimed liability
    based on “any and all liability that may be based on . . . information or errors . . . or
    omissions” from any representations outside of Articles III and IV, as modified by
    73
    Purchase Agreement § 2.6.
    74
    Id.
    41
    the Company Disclosure Letter.75 The Preliminary Closing Statement is neither
    referenced in nor part of any representation or warranty by the Sellers in Article III
    or the Company in Article IV, as those articles are modified by the Company
    Disclosure Letter. 76 Thus, by the contract’s terms, Buyer agreed that it was not
    relying on the Preliminary Closing Statement and cannot claim justifiable reliance
    on it.
    Delaware law enforces such agreements. Abry Partners analyzed Delaware
    jurisprudence on anti-reliance clauses and held that “this court has . . . honored
    contracts that define those representations of fact that formed the reality upon which
    the parties premised their decision to bargain.” Abry, 
    891 A.2d at 1058
    ; see also
    Prairie Capital, 132 A.3d at 51 (“If a party represents that it only relied on particular
    information, then that statement establishes the universe of information on which
    that party relied.”); FdG Logistics LLC v. A&R Logistics Hldgs., Inc., 
    131 A.3d 842
    ,
    858 (Del. Ch. 2016) (“Delaware law enforces clauses which identify the specific
    75
    
    Id.
     Section 2.6 contains language disclaiming claims arising from omissions and, as a
    result, Buyer’s claims relating to allegedly fraudulent omissions are barred. See Pilot Air
    Freight, 
    2020 WL 5588671
    , at *22 n.215 (discussing disclaimer of fraudulent omission
    claims). That is not to say, however, that express language disclaiming claims based on
    omissions is required to preclude a claim based upon an alleged omission. See Prairie
    Capital, 132 A.3d at 52–55 (holding an exclusive presentations clause need not “use magic
    words like ‘omissions’” to preclude claims based upon alleged omissions).
    76
    Buyer does not argue that the Preliminary Closing Statement is part of any representation
    in Article III or IV, as modified by the Company Disclosure Letter, and has waived any
    argument to the contrary.
    42
    information on which a party has relied and foreclose reliance on other
    information.”); ChyronHego, 
    2018 WL 3642132
    , at *1 (“Where the parties in
    language that is clear provide that they eschew reliance on any facts but those recited,
    they will be held to that representation, notwithstanding prior knowingly false
    statements made by one party to the other.”). Accordingly, “[t]he net effect of an
    enforceable non-reliance provision and carefully negotiated representations and
    warranties”—both elements of which are present in the Purchase Agreement—“is to
    define what information the Buyer relied upon in deciding to execute the [contract].”
    Pilot Air Freight, 
    2020 WL 5588671
    , at *23 (internal quotations omitted).
    Buyer does not contend that the contractual language is not sufficiently
    specific to preclude any claim that Buyer relied on representations and warranties
    outside of Articles III and IV. Rather, Buyer argues that Delaware law generally
    does not permit disclaimer of any representation “within” the contract and that it was
    entitled to rely on the Preliminary Closing Statement. Buyer’s Ans. Br. in Opp’n to
    Mot. to Dismiss 36 (quoting RAA Mgmt., LLC v. Savage Sports Hldgs., Inc., 
    45 A.3d 107
    , 117 (Del. 2012)). Buyer’s argument appears to be that, under Delaware law,
    parties to a contract cannot disclaim reliance on any document referenced in the
    contract.
    This argument fails for multiple reasons. First, RAA does not stand for the
    proposition that the parties may not disclaim reliance upon any document referenced
    43
    in the contract. In RAA, the Delaware Supreme Court considered a non-disclosure
    agreement in which a company represented that it was not making “any
    representation or warranty” regarding information provided to a prospective
    purchaser through due diligence.         RAA, 
    45 A.3d at 110
    .77          The parties had
    “terminated negotiations . . . before the parties executed a final sale agreement.” 
    Id. at 109
    . RAA quoted Abry Partners for the proposition that “fraud claims based on
    ‘false representation[s] of fact made within the contract itself’ . . . cannot be
    disclaimed.” 
    Id. at 117
    . In both RAA and Abry Partners, however, the anti-reliance
    clauses drew the dividing line at the four corners of the contract, and those cases
    analyzed the effect of the anti-reliance clauses consistent with their express terms.78
    RAA and Abry do not, as Buyer argues, impose a broader rule that parties to a
    contract may not disclaim reliance on anything “within” the contract, regardless of
    77
    In RAA, the Delaware Supreme Court “assume[d] that New York law applies, but
    conclude[d] that the outcome would be the same under Delaware law.” RAA, 
    45 A.3d at 112
    .
    78
    RAA, 
    45 A.3d at 110
     (“Only those representations or warranties that are made to a
    purchaser in the Sale Agreement . . . shall have any legal effect.”); Abry, 
    891 A.2d at 1041
    (“Acquiror . . . agrees that neither the Company nor the Selling Stockholder has made any
    representation or warranty . . . except as expressly set forth in this Agreement”).
    44
    the language of the parties’ anti-reliance provision. 79
    Second, permitting Buyer to rely on a document outside Articles III and IV
    would render the references to Articles III and IV in the anti-reliance provision
    surplusage, effectively requiring the Court to rewrite the parties’ agreement as to the
    universe of contractual representations that Buyer relied upon. Buyer has not cited
    any case in which the Court has done so. See Osborn, 
    991 A.2d at 1159
     (“We will
    read a contract as a whole and we will give each provision and term effect, so as not
    to render any part of the contract mere surplusage. We will not read a contract to
    render a term meaningless or illusory.”) (internal quotations and citations omitted).
    Third, adopting Buyer’s reasoning and abandoning the parties’ agreed-upon
    definition of the representations and warranties in the Purchase Agreement would
    defeat the purpose of anti-reliance clauses. As the Court held in Abry, “[t]his sort of
    definition minimizes the risk of erroneous litigation outcomes by reducing doubts
    about what was promised and said, especially because the contracting parties have
    79
    In this context, terms such as “extra-contractual” can be viewed as distinguishing
    between the information that a party has agreed it relied upon in entering into the contract,
    and the information that the contracting parties agreed that a party has not relied upon. See,
    e.g., ChyronHego, 
    2018 WL 3642132
    , at *4–5 (discussing “extra-contractual”
    representations and warranties in the context of “clauses that identify the specific
    information on which a party has relied”) (internal citations omitted); see also FdG
    Logistics, 131 A.3d at 858 (“Delaware law enforces clauses which identify the specific
    information on which a party has relied and foreclose reliance on other information.”)
    (citing RAA, 
    45 A.3d at
    116–17). Buyer’s position would restrict generally the parties’
    ability to disclaim reliance upon the representations and warranties of their choosing.
    45
    defined that in writing in their contract.” Abry, 
    891 A.2d at 1058
    . Permitting Buyer
    to advance a fraud claim based on the Preliminary Closing Statement would
    introduce the exact kind of uncertainty that anti-reliance clauses are intended to
    foreclose.80   Thus, having disclaimed reliance upon the Preliminary Closing
    Statement, Buyer cannot now claim that it justifiably relied upon the Preliminary
    Closing Statement in entering into the Purchase Agreement. See Abry, 
    891 A.2d at 1058
     (noting that failing to enforce anti-reliance clauses would “excuse a lie made
    by one contracting party in writing—the lie that it was relying only on contractual
    representations and that no other representations had been made”). Buyer’s fraud
    claim arising from the Preliminary Closing Statement therefore is dismissed.
    b.     Fraudulent Concealment (Count IV)
    Count IV (Fraudulent Concealment) alleges that Counterclaim Defendants
    “deliberately concealed material facts from [Buyer] in relation to the calculation of
    Closing Net Working Capital and with respect to the financial position of the
    Company prior to or at closing.” Countercl. ¶ 40.
    To allege fraudulent concealment, the Buyer must allege that Counterclaim
    Defendants “took some action affirmative in nature designed or intended to prevent,
    and which does prevent, the discovery of facts giving rise to the fraud claim, some
    80
    See ChyronHego, 
    2018 WL 3642132
    , at *7 (dismissing an “attempt to bootstrap a dog’s
    breakfast of extra-contractual fraud claims onto contractual misrepresentations” because
    the alleged misrepresentations were outside the company’s “ordinary course of business”).
    46
    artifice to prevent knowledge of the facts or some representation intended to exclude
    suspicion and prevent inquiry.”         Metro Commc'n Corp. BVI v. Advanced
    Mobilecomm Techs. Inc., 
    854 A.2d 121
    , 150 (Del. Ch. 2004) (internal citations
    omitted); accord Corp. Prop. Assocs. 14 Inc. v. CHR Hldg. Corp., 
    2008 WL 963048
    ,
    at *7 (Del. Ch. Apr. 10, 2008). As with fraud, to plead fraudulent concealment,
    Buyer must also satisfy the heightened pleading standard of Court of Chancery Rule
    9(b).
    Buyer’s allegations of concealment are conclusory and lack particularity. See,
    e.g., Countercl. ¶ 4 (“Sellers[,] including Hansen, . . . acted fraudulently so as to
    intentionally conceal financial information from Buyers [sic], with respect to the
    calculation of Closing Net Working Capital, so as to significantly overstate the
    Company’s current assets, and, grossly understate its current liabilities.”); ¶ 9
    (“Upon information and belief, Sellers, including at the express direction of and by
    and through Hansen, and on behalf of the Company, intentionally concealed and
    withheld information concerning the degradation of the carrying value of the
    Moviepass account, from both the financial statements disclosed to [Buyer] prior to
    closing as well as from the Preliminary Closing Statement.”); ¶ 10 (“In internal email
    correspondence prior to the Closing the Company made clear its concern regarding
    the Moviepass receivable. Thus, there was a degradation of the carrying value of
    the account prior to the Closing of which Sellers—and their CFO and Manager,
    47
    Hansen—were well aware, and yet intentionally ignored and/or withheld such
    information, including by failing to estimate a sufficient reserve for the Moviepass
    account in the financial statements furnished to [Buyer] prior to closing . . . .”); ¶ 17
    (“Sellers, including by and through Hansen, intentionally withheld such information
    concerning the outstanding checks of which they were well aware at the time of
    closing . . . .”); ¶ 18 (“Sellers and Hansen obviously knew about the outstanding
    checks but intentionally and fraudulently did not advise and concealed them from
    Buyer, so as to understate the Company’s Accounts Payable.”); ¶ 25 (“Following the
    [Determination Letter], Buyer learned of additional bad faith conduct and fraud by
    Sellers who, upon information and belief, have intentionally concealed information
    that ‘past practices’ as well as unsigned agreements, provide for merit increases” and
    bonuses for certain management).
    Buyer has not met its pleading burden as to any of the financial information
    forming the basis of the fraudulent concealment claim. Buyer does not allege with
    the required particularity a single fact of concealment. See Bay Ctr. Apts. Owner,
    LLC v. Emery Bay PKI, LLC, 
    2009 WL 1124451
    , at *12 (Del. Ch. Apr. 20, 2009)
    (dismissing fraudulent concealment claim based upon allegations that “defendants
    failed to share with [plaintiff] important information that the defendants knew by
    virtue of their positions as the day-to-day managers of the Project. But it cannot be
    reasonably inferred from the Complaint that the defendants made any effort to hide
    48
    this information from [plaintiff] through subterfuge or other artifice.”); cf. Swipe
    Acq. Corp. v. Krauss, 
    2020 WL 5015863
    , at *3 (Del. Ch. Aug. 25, 2020) (sustaining
    fraud claim upon allegations that President and CEO told employees that if buyer
    learned of the impending loss of a major customer “the deal would be ‘over’” and
    detailing how CEO orchestrated a due diligence call so as to limit buyer’s ability to
    learn of the loss of the major customer).
    To be sure, before closing, the Buyer was provided with “full and complete
    access to the Representatives, properties, offices, plants and other facilities, books
    and records of the Company and its Subsidiaries and other information that they
    have requested in connection with their investigation of the Company and its
    Subsidiaries.” Purchase Agreement § 2.6. After closing, Buyer owned the Company
    and its records, possessed its emails, and had access to its employees, yet Buyer has
    not alleged any specific act designed to prevent Buyer’s discovery of the financial
    information underlying the fraud claim. 81 The particularity requirement of Rule 9(b)
    is “applied in light of the facts of the case, and less particularity is required when the
    facts lie more in the knowledge of the opposing party than of the pleading party.”
    H-M Wexford LLC v. Encorp, Inc., 
    832 A.2d 129
    , 146 (Del. Ch. 2003). In light of
    the facts of this case, Buyer does not get the benefit of having to plead with “less
    81
    See Oral Arg. Tr. at 43–44 (counsel for Buyer acknowledging Buyer’s possession of the
    Company’s emails).
    49
    particularity.” Nor can the Buyer satisfy its burden to plead with particularity by
    alleging an act of concealment based upon “information and belief.” Countercl. ¶¶ 9,
    10, 25; Metro Comm’cn, 854 A.2d at 149 n.57; Nutt v. A.C. & S., Inc., 
    466 A.2d 18
    ,
    23 (Del. Super. 1983), aff’d sub nom. Mergenthaler v. Asbestos Corp. of Am., 
    480 A.2d 647
     (Del. 1984); cf. Wexford, 
    832 A.2d at 146
     (acknowledging that intent and
    knowledge pleaded upon information and belief can satisfy Rule 9(b)).
    B.     Sellers’ Motion for Summary Judgment
    Sellers have moved for summary judgment in their favor on all counts of their
    Complaint, which seeks an order confirming the Determination Letter as a binding
    arbitration award and for specific performance compelling release of the escrow
    pursuant to the Determination Letter.
    Under Court of Chancery Rule 56, summary judgment may be granted if
    “there is no genuine issue as to any material fact and . . . the moving party is entitled
    to judgment as a matter of law.” Ct. Ch. R. 56(c). As with the motion to dismiss,
    the Court “must view the evidence in the light most favorable to the non-moving
    party.” 82 “A motion for summary judgment is the ‘common [method] for this court
    to determine whether to vacate or confirm an arbitration award.’” TD Ameritrade,
    Inc. v. McLaughlin, Piven, Vogel Sec., Inc., 
    953 A.2d 726
    , 730 (Del. Ch. 2008)
    82
    Merrill v. Crothall-Am., Inc., 
    606 A.2d 96
    , 99 (Del. 1992).
    50
    (quoting Beebe Med. Ctr., Inc. v. InSight Health Servs. Corp., 
    751 A.2d 426
    , 431
    (Del. Ch. 1999)).
    The parties agree that the Court’s decision to confirm or vacate the
    Determination Letter is governed by the Federal Arbitration Act. 83 Under the
    Federal Arbitration Act, a court designated to confirm the award in the contract must
    grant an application to confirm the award “unless the award is vacated, modified, or
    corrected as prescribed in sections 10 and 11” of the FAA. 84 Buyer argues that the
    Determination Letter should be vacated pursuant to 
    9 U.S.C. § 10
    (a)(1) as an award
    “procured by . . . fraud, or undue means.” 85
    Because Buyer has pleaded a claim for fraud arising from the Management
    Bonus Liabilities and the Medical Claim Liabilities, there is a material issue of fact
    preventing entry of summary judgment.               Specifically, it is possible that the
    Determination Letter was procured by fraud to the extent that the omission of the
    Management Bonus Liabilities and the Medical Claim Liabilities from the Interim
    83
    See Buyer’s Ans. Br. in Opp’n to Summ. J. 38 (“Defendant’s basis for seeking vacatur
    of the PwC Award is the FAA, 
    9 U.S.C. § 10
    (a)(1)”); Sellers’ Reply Br. in Supp. of Summ.
    J. 1 (arguing that Buyer has not timely filed a motion to vacate and that Buyer has not
    demonstrated the award was procured by fraud).
    84
    
    9 U.S.C. § 9
    . The parties specified that “[j]udgment may be entered upon the written
    determination of the Independent Accounting Firm in accordance with Section 8.10.”
    Purchase Agreement § 1.3(d). Section 8.10 is a forum selection clause selecting the Court
    of Chancery as the forum of first resort. Id. § 8.10.
    85
    Buyer’s Ans. Br. in Opp’n to Summ. J. 38–39.
    51
    Financial Statements formed part of the calculations relied upon by PwC in its
    Determination Letter. 86 In addition, “further development of the factual record and
    the parties’ legal arguments would help clarify the application of the law to the
    circumstances of the case.” Bouchard v. Braidy Indus., Inc., 
    2020 WL 2036601
    , at
    *16 (Del. Ch. Apr. 28, 2020).87 Accordingly, the Motion for Summary Judgment is
    denied without prejudice.
    86
    It is not clear from the limited record before the Court to what extent PwC evaluated the
    Management Bonus Liabilities and Medical Claim Liabilities before issuing the
    Determination Letter. Buyer alleges that the Management Bonus Liabilities and Medical
    Claim Liabilities were “learned of” “following the [Determination Letter].” Countercl.
    ¶¶ 25–26. At page 14 of the Determination Letter, however, Buyer appears to have
    disputed “[a]n underaccrual of accounts payable related to medical claims.” Determination
    Letter 14. PwC ruled in the Sellers’ favor on this issue because the medical claim liabilities
    referenced in the Determination Letter were not included in the Final Closing Statement.
    
    Id.
     at 14–15. As discussed above, additional development of the facts will assist the Court
    in determining whether summary judgment is appropriate for confirmation of the
    Determination Letter.
    87
    In their Reply Brief in Support of their Motion for Summary Judgment, Sellers argued,
    for the first time, that Buyer did not timely file a motion to vacate the Determination Letter
    because Buyer did not file a motion to vacate the Determination Letter within 90 days
    pursuant to 
    9 U.S.C. § 12
    . The Court recognizes that this issue arose in an awkward
    procedural context due to the Buyer’s filing of amended counterclaims and altering its legal
    theory after Sellers filed their opening brief. Nevertheless, because Sellers raised the issue
    for the first time in their reply brief, Buyer did not have the opportunity to respond in its
    Answering Brief. “Normally, this court does not entertain arguments raised for the first
    time in a reply brief.” Pryor v. IAC/InterActiveCorp., 
    2012 WL 2046827
    , at *6 n.71 (Del.
    Ch. June 7, 2012). Having determined that there is a genuine issue of material fact
    preventing summary judgment, the Court concludes that the Buyer should be permitted to
    appropriately address the procedural challenge to its attempt to vacate the Determination
    Letter pursuant to 
    9 U.S.C. § 12
    .
    52
    III.   CONCLUSION
    For the foregoing reasons, the Counterclaim Defendants’ Motion to Dismiss
    the Counterclaims is granted as to Counts I, IV, and V, and granted in part and denied
    in part as to Count II. Plaintiffs’ Motion for Summary Judgment is denied without
    prejudice.
    IT IS SO ORDERED.
    53
    

Document Info

Docket Number: C.A. No. 2019-0585-PAF

Judges: Fioravanti V.C.

Filed Date: 9/30/2020

Precedential Status: Precedential

Modified Date: 9/30/2020

Authorities (21)

RAA Management, LLC v. Savage Sports Holdings, Inc. , 45 A.3d 107 ( 2012 )

Winshall v. Viacom International Inc. , 76 A.3d 808 ( 2013 )

Nemec v. Shrader , 991 A.2d 1120 ( 2010 )

Dunlap v. State Farm Fire & Casualty Co. , 878 A.2d 434 ( 2005 )

Malpiede v. Townson , 780 A.2d 1075 ( 2001 )

In Re General Motors (Hughes) Shareholder Litigation , 897 A.2d 162 ( 2006 )

Trenwick America Litigation Trust v. Ernst & Young, L.L.P. , 906 A.2d 168 ( 2006 )

H-M Wexford LLC v. Encorp, Inc. , 832 A.2d 129 ( 2003 )

Trenwick America Litigation Trust v. Billett , 931 A.2d 438 ( 2007 )

Savor, Inc. v. FMR Corp. , 812 A.2d 894 ( 2002 )

Central Mortgage Co. v. Morgan Stanley Mortgage Capital ... , 27 A.3d 531 ( 2011 )

Merrill v. Crothall-American, Inc. , 606 A.2d 96 ( 1992 )

Estate of Osborn Ex Rel. Osborn v. Kemp , 991 A.2d 1153 ( 2010 )

Mergenthaler v. Asbestos Corp. of America , 480 A.2d 647 ( 1984 )

Interim Healthcare, Inc. v. Spherion Corp. , 884 A.2d 513 ( 2005 )

Airborne Health, Inc. v. Squid Soap, LP , 984 A.2d 126 ( 2009 )

Abry Partners V, L.P. v. F & W Acquisition LLC , 891 A.2d 1032 ( 2006 )

Wilgus v. Salt Pond Investment Co. , 498 A.2d 151 ( 1985 )

Beebe Medical Center, Inc. v. InSight Health Services Corp. , 751 A.2d 426 ( 1999 )

TD Ameritrade, Inc. v. McLaughlin, Piven, Vogel Securities, ... , 953 A.2d 726 ( 2008 )

View All Authorities »